A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer

NCT01694589 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Lack of accrual

Conditions

Interventions

Sponsor

Rutgers, The State University of New Jersey

Collaborators